A new trading day began on Monday, with Precigen Inc (NASDAQ: PGEN) stock price down -8.38% from the previous day of trading, before settling in for the closing price of $1.91. PGEN’s price has ranged from $0.65 to $2.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -15.17%. Meanwhile, its annual earnings per share averaged -17.31%. With a float of $162.74 million, this company’s outstanding shares have now reached $292.87 million.
Let’s determine the extent of company efficiency that accounts for 202 employees. In terms of profitability, gross margin is -63.15%, operating margin of -3277.95%, and the pretax margin is -3573.1%.
Precigen Inc (PGEN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Precigen Inc is 44.43%, while institutional ownership is 26.16%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -17.31% per share during the next fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Here are Precigen Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 129.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Looking closely at Precigen Inc (NASDAQ: PGEN), its last 5-days average volume was 1.75 million, which is a drop from its year-to-date volume of 2.15 million. As of the previous 9 days, the stock’s Stochastic %D was 47.61%. Additionally, its Average True Range was 0.16.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 72.34%, which indicates a significant increase from 52.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.49% in the past 14 days, which was lower than the 91.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2462, while its 200-day Moving Average is $1.2069. However, in the short run, Precigen Inc’s stock first resistance to watch stands at $1.8700. Second resistance stands at $1.9900. The third major resistance level sits at $2.0550. If the price goes on to break the first support level at $1.6850, it is likely to go to the next support level at $1.6200. Should the price break the second support level, the third support level stands at $1.5000.
Precigen Inc (NASDAQ: PGEN) Key Stats
With a market capitalization of 512.52 million, the company has a total of 292,869K Shares Outstanding. Currently, annual sales are 6,230 K while annual income is -95,900 K. The company’s previous quarter sales were 950 K while its latest quarter income was -23,980 K.
